Summary
The occurrence and coexpression of the cytoskeletal proteins vimentin and cytokeratins were studied in malignant mesotheliomas and pulmonary carcinomas. For this purpose a double immunoenzyme staining with monoclonal antibodies was developed which made it possible to visualize vimentin and cytokeratins simultaneously within the same cell. A clear distinction between stromal cells (vimentin only) and tumour cells was also obtained.
A total of 12 mesotheliomas (six mixed type and six epithelioid type) and 13 carcinomas (eight adenocarcinomas and five large cell undifferentiated carcinomas) were studied.
The results revealed a clear difference between mesotheliomas and adenocarcinomas: 11 of 12 mesotheliomas showed coexpression of vimentin and cytokeratins in at least 50% of the tumour cells, while in seven of the eight adenocarcinomas none or only a few cells could be seen with this coexpression. In the undifferentiated large cell carcinomas three of five expressed both components, but in less than 25% of the cells.
It is concluded that a reliable double immunoenzyme staining of vimentin and cytokeratins can be used as an additional means to distinguish malignant mesothelioma from pulmonary adenocarcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blobel GA, Moll R, Franke WW, Kayser KW, Gould VE (1985) The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol 121:235–247
Boorsma DM (1984) Direct immunoenzyme double staining applicable for monoclonal antibodies. Histochemistry 80:103–106
Caselitz J, Becker J, Seifert G, Weber K, Osborn M (1984) Coexpression of keratin and vimentin filaments in adenoid cystic carcinomas of salivary glands. Virchows Arch [Pathol Anat] 403:337–344
Churg A (1985) Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol 9:360–365
Churg J, Rosen SH, Moolten S (1965) Histological characterization of mesothelioma associated with asbestosis. Ann NY Acad Sci 132:614–622
Connel ND, Rheinwald JG (1983) Regulation of the cytoskeleton in mesothelial cells: a reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 34:245–253
Corson JM, Pinkers GS (1982) Mesothelioma: Profile of keratin proteins and CEA. An immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol 108:80–87
Fisher ER, Hellstrom R (1960) The periodic acid-Schiff reaction as an aid in the identification of mesothelioma. Cancer: 13:837–841
Franke WW, Schmid E, Winter S, Osborn M, Weber K (1979) Widespread occurrence of intermediatel-sized filaments of the vimentin type in cultured cells from diverse vertebrates. Exp Cell Res 123:25–46
Gibbs AR, Harach NR, Wagner JC, Jasani B (1985) Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma. Thorax 40:91–95
Henzen-Logmans SC, Mullink H, Ramaekers FCS, Meijer CJLM (1985) Cytokeratin patterns and co-expression of cytokeratin and vimentin in epithelial cells of normal and pathologic thyroid glands. Pathol Res Pract 180:276–277
Herman CJ, Moesker O, Kant A, Huysman A, Vooys P, Ramaekers FCS (1983) Is renal cell (Grawitz) tumor a carcinosarcoma? Virchows Arch [Cell Pathol] 44:73–83
Jasani B, Edwards RE, Thomas ND, Gibbs AR (1985) The use of vimentin antibodies in the diagnosis of malignant mesotheliomas. Virchows Arch [Pathol Anat] 406:44–448
Kannerstein M, Churg J, Magner D (1973) Histochemistry in the diagnosis of malignant mesothelioma. Ann Clin Lab Sci 3:207–211
Kwee WS, Veldhuizen RW, Golding RP, Mullink H, Stam J, Donner D, Boon ME (1982) Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of application of morphometry combined with histochemistry and immunostaining. Virchows Arch [Pathol Anat] 397:287–299
La Rocca P, Rheinwald JG (1984) Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. Cancer Res 44:2991–2999
Loosli H, Hurlimann J (1984) Immunohistochemical study of malignant mesotheliomas of the pleura. Histopathology 8:793–803
Mason DY, Sammons R (1978) Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol 31:454–460
McNutt MA, Bolen JW, Gown AM, Hammar SP, Vogel AM (1985) Coexpression of intermediate filaments in human epithelial neoplasms. Ulstrastruct Pathol 9:31–43
Miettinen M, Fransilla K, Lehto V, Paasivo R, Virtanen I (1984) Expression of intermediate filament proteins in thyroid gland and thyroid tumors. Lab Invest 50:262–269
Mukai M, Torikata C, Iri H, Hanaoka H, Kawai T (1985 a Cellular differentiation of epithelioid sarcoma. An electron-microscopic, enzyme-histochemical and immunohistochemical study. Am J Pathol 119:44–56
Mukai K, Holden J, Churg A (1985b) Malignant mesothelioma and CEA staining. Am J Surg Pathol 9:159–160
Mullink H, Boorsma D, Henzen-Logmans SC, Meijer CJLM (1986) Double immunoenzyme staining methods with special reference to monoclonal antibodies. In: Ruiter DJ, Fleuren GJ, Warnaar S (eds) Applications of monoclonal antibodies in tumor pathology. Martinus Nijhof, Dordrecht (in press)
Muijen van GNP, Ruiter DJ, Ponec M (1984) Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumours. Am J Pathol 114:9–17
Nakane PK (1968) Simultaneous localisation of multiple tissue antigens using the peroxidaselabelled antibody method. J Histochem Cytochem 16:557–560
Osborn M, Weber K (1983) Biology of disease. Tumor diagnosis by intermediate filament typing a novel tool for surgical pathology. Lab Invest 48:372–394
Osborn M, Franke W, Weber K (1980) Direct demonstration of the presence of two immunologically distinct intermediate-sized filament systems in the same cell by double immunofluorescence microscopy. Exp Cell Res 125:37–46
Ramaekers FCS, Haag D, Kant A, Moesker O, Jap PHK, Vooys GP (1983) Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci USA 80:2618–2622
Ramaekers FCS, Haag D, Jap P, Vooys GP (1984) Immunochemical demonstration of keratin and vimentin in cytologic aspirates. Acta Cytol 28:385–392
Szpak CA, Johnston WW, Roggli V, Kolbechk J, Lottich GC, Vollmer R, Thor A, Schlom J (1986) The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B 72.3). Am J Pathol 122:252–260
Talerman A, Montero JR, Chilcote RR, Okagaki (1985) Diffuse malignant peritoneal mesothelioma in a 13-year-old girl. Am J Surg Pathol 9:73–80
Virtanen I, Lehto VP, Lehtonen E, Vartio T, Stenman S, Kurki P, Wagner O, Small JV, Dahl D, Badly RA (1981) Expression of intermediate filaments in cultured cells. J Cell Sci 50:45–63
Wagner JC, Munday DE, Harington JS (1962) Histochemical demonstration of hyaluronic acid in pleural mesotheliomas. J Pathol Bact 84:73–78
Whitaker D, Shilkin KB (1984) Diagnosis of pleural malignant mesothelioma in life — a practical approach. J Pathol 143:147–175
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mullink, H., Henzen-Logmans, S.C., Alons-van Kordelaar, J.J.M. et al. Simultaneous immunoenzyme staining of vimentin and cytokeratins with monoclonal antibodies as an aid in the differential diagnosis of malignant mesothelioma from pulmonary adenocarcinoma. Virchows Archiv B Cell Pathol 52, 55–65 (1986). https://doi.org/10.1007/BF02889950
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02889950